Early start of dialysis: A critical review

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1222-1228

  Rosansky, Steven ^a   Glassock, Richard J ^b   Clark, William F ^c  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; DIALYSIS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MORBIDITY; MORTALITY; NUTRITION; NUTRITIONAL PARAMETERS; OBSERVATIONAL STUDY; QUALITY OF LIFE; REVIEW; UNITED STATES; UREMIA;

EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; NEPHROLOGY; RENAL DIALYSIS; TIME FACTORS;

EID: 79957861399     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09301010     Document Type: Review

References (76)

1. Bonomini V, Feletti C. Scolari MP, Stefoni S: Benefits of earlyinitiation of dialysis. Kidney Int 28[Suppl 17]: S57-S59, 1985
2. Cantera-Munoz P, Ruano-Ravina A, Otero-Gonzalez A, Sanches-Guisande D, Rodriguez LG: Influence of early dialysisamong patients with advanced chronic renal disease: Resultsof a systematic review. Nephrol Dial Transplant 25:2414-2421, 2010
3. Tattersall J, Greenwood R, Farrington K: Urea kinetics andwhen to commence dialysis. Am J Nephrol 15: 283-289,1995
4. Hakim RM, Lazarus JM: Initiation of dialysis. J Am Soc Nephro l6: 1319-1328, 1995
5. Churchill DN: An evidence-based approach to earlier initiationof dialysis. Am J Kidney Dis 30: 899-906, 1997
6. Rosansky SJ, Clark WF, Eggers P, Glassock R: Initiation ofdialysis at higher GFRs: is the apparent rising tide of earlydialysis harmful or helpful? Kidney Int 76: 257-261, 2009
7. European Renal Association-European Dialysis and TransplantAssociation: Nephrol Dial Transplant 17: 10-11, 2002
8. US Renal Data System: USRDS 2009 Annual Data Report,Bethesda, MD, National Institutes of Health, National Instituteof Diabetes and Digestive and Kidney Diseases, 2009
9. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of hemodialysisprescription on patient morbidity. N Engl J Med 305:1176-1181, 1981
10. Gotch FA, Sargent JA: A mechanistic analysis of the NationalCooperative Dialysis Study (NCDS). Kidney Int 286: 526-534, 1985
11. Lowrie EG, Lew NL, Huang WH: Race and diabetes as deathrisk predictors in hemodialysis patients. Kidney Int 42[Suppl38]: S22-S31, 1992
12. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The ureareduction ratio and serum albumin concentration as predictorsof mortality in patients undergoing hemodialysis. N EnglJ Med 329: 1001-1006, 1993
13. Canada-USA (CANUSA) Peritoneal Dialysis Study Group:Adequacy of dialysis and nutrition in continuous peritonealdialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198-207, 1996
14. Paniagua R, Anato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, for the Mexican Nephorlogy CollaborativeStudy Group: Effects of increased peritoneal clearances onmortality rates in peritoneal dialysis: ADEMEX, a prospective,randomized, controlled trial. J Am Soc Nephrol 13: 1307-1320, 2002
15. Eknoyan G, Beck GJ, Alfred K, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP,Toto R, for the Hemodialysis (HEMO) Study Group: Effect ofdialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
16. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SMH, Zhu X, Lazarus JM: Associates of mortality among peritoneal dialysispatients with special reference to peritoneal transport ratesand solute clearance. Am J Kidney Dis 33: 523-534, 1999
17. Caravaca F, Arrobas M, Dominguez C: Influence of residualrenal function on dietary protein and caloric intake in patientson incremental peritoneal dialysis. Perit Dial Int 19:350-356, 1999
18. Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, Ohtani A, Nakashima Y: The contribution of residualrenal function to overall nutritional status in chronichemodialysis patients. Nephrol Dial Transplant 15: 396-401,2000
19. Shemin D, Bostom AG, Laliberty P, Dworkin LD: Residualrenal function and mortality risk in hemodialysis patients. Am J Kid Dis 38: 85-90, 2001
20. Bargman JM, Thorpe KE, Churchill DN: Relative contributionof residual renal function and peritoneal clearance to ade-quacy of dialysis: A reanalysis of the CANUSA study. J AmSoc Nephrol 12: 2158-2162, 2001
21. Ikizler TA, Greene JH, Wingard RL, Hakim RM: Spontaneousdietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6: 1386-1391, 1995
22. Hakim RM, Levin N: Malnutrition in hemodialysis patients. Am J Kid Dis 21: 125-137, 1993
23. Bergstrom J: Nutrition and mortality in hemodialysis. J AmSoc Nephrol 6: 1329-1341, 1995
24. Pupim LB, Kent P, Caglar K, Shyr Y, Hakim RM, Ikizler TA: Improvement in nutritional parameters after initiation ofchronic hemodialysis. Am J Kid Dis 40: 143-151, 2002
25. Mehrotra R, Bermann, Alistwani A, Kopple JD: Improvementof nutritional status after initiation of maintenance hemodialysis. Am J Kid Dis 40: 133-142, 2002
26. Caglar K, Fedje L, Dimmitt R, Hakim RM, Shyr Y, Ikizler TA: Therapeutic effects of oral nutritional supplementation duringhemodialysis. Kidney Int 62: 1054-1059, 2002
27. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, Poole D, Uhlin L, for the HEMO Study Group: The effect ofdialysis dose and membrane flux on nutritional parameterson hemodialysis patients: Results of the HEMO Study. KidneyInt 65: 2321-2334, 2004
28. Kaysen GA, Dubin JA, Muller HG, Rosales L, Levin NW, Mitch WE: Inflammation and reduced albumin synthesis associatedwith stable decline in serum albumin in hemodialysispatients. Kidney Int 65: 1408-1415, 2004
29. Friedman AN, Fadem SZ: Reassessment of albumin as a nutritionalmarker in kidney disease. J Am Soc Nephrol 21: 223-230, 2010
30. Ledebo I, Kessler M, van Biesen W, Wanner C, Wiecek A, Prichard S, Argiles A, Ritz E: Initiation of dialysis: Opinionsfrom an international survey: Report on the dialysis opinionsymposium at the ERA-EDTA Congress, 18 September 2000, Nice. Nephrol Dial Transplant 16: 1132-1138, 2001
31. McIntyre CW: Effects of hemodialysis on cardiac function. Kidney Int 76: 1-5, 2009
32. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4: 914-920, 2009
33. Sniderman AD, Solhpour A, Alam A, Williams K, Sloand JA: Cardiovascular death in dialysis patients: Lessons we canlearn from AURORA. Clin J Am Soc Nephrol 5: 335-340,2010
34. Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al, Khatib SM, Middleton JP, Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Lash JP, Leas JP, Lewis JB, Lipkowski MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, for the AASK Collaborative ResearchGroup: Chronic kidney disease associated with increased riskof sudden cardiac death among patients with coronary arterydisease. Kidney Int 76: 652-658, 2009
35. Canaud B, Chenine L, Leray-Moragues H, Wiesen H, Tetta C: Residual renal function and dialysis modality: is it really beneficialto preserve residual renal function in dialysis patients? Nephrology 11: 292-296, 2006
36. Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM: Blood pressure in chronic kidney disease stage 5D: Reportfrom a kidney disease: Improving global outcomes controversiesconference. Kidney Int 77: 273-284, 2009
37. Korevaar JC, Jansen MA, Dekker FW, Jager KJ, Boeschoten EW, Krediet RT, Bossuyt PMM, for the Netherlands Cooperative Study on the Adequacy of Dialysis Study Group: Whento initiate dialysis: Effect of proposed US guidelines on survival. Lancet 358: 1046-1050, 2001
38. Traynor JP, Simpson K, Geddes CC, Deighan CJ, Fox JG: Early initiation of dialysis fails to prolong survival in patientswith end-stage renal failure. Clin J Am Soc Nephrol 13:2125-2132, 2002
39. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Ramkumar N, Pappas LM, Cheung AK: Impact of timing of initiation ofdialysis on mortality. J Am Soc Nephrol 14: 2305-2312,2003
40. Sawhney S, Djurdjev O, Simpson K, Macleod A, Levin A:Survival and dialysis initiation: Comparing British Columbiaand Scotland registries. Nephrol Dial Transplant 24: 3186-3192, 2009
41. Stel VA, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, Finne P, Ioannidis GA, Salomone M, Traynor JP, Zurriaga O, Verrina E, Jager KJ: Residual renal function at thestart of dialysis and clinical outcomes. Nephrol Dial Transplant 24: 3175-3182, 2009
42. LaSalle M, Labeeuw M, Frimat L, Villar E, Joyeux V, Couchoud C, Stengel B, on behalf of the REIN Registry. Ageand comorbidity explain the paradoxical association of earlydialysis starts with poor survival. Kidney Int 77: 700-707,2010
43. Hwang S, Yang W, Lin M, Mau Lw, Chen HC, and Taiwan Society of Nephrology: Impact of the clinical conditions atdialysis initiation on mortality in incident haemodialysis patients'national cohort study in Taiwan. Nephrol Dial Transplant 25: 2616-2624, 2010
44. Wright S, Klausner D, Bradley B, Williams ME, Steinman T, Tang H, Ragasa R, Goldfard-Rumyantzev AS: Timing of dialysisinitiation and survival in ESRD. Clin J Am Soc Nephrol 5:1828-1835, 2010
45. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kessehut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA, for the IDEAL Study: A randomized controlled trial of early versus late initiationof dialysis. N Engl J Med 363: 606-619, 2010
46. Clark WF, Na Y, Rosansky SJ, Sontrop JM, Macnab JJ, Glassock RJ, Eggers P, Jackson K, Moist L: Estimated glomerularfiltration rate at dialysis initiation and mortality. CMAJ 183:47-53, 2010
47. Rosansky SJ, Eggers P, Jackson K, Glassock R, Clark WF: Early start of hemodialysis may be harmful. Arch Intern Med 17: 396-403, 2011
48. Grootendorst DC, Michels MW, Richardson JD, Jager KJ, Boeschoten EW, Dekker FW, Krediet RT, For the NECOSAD Study Group: The MDRD formula does not reflect GFR in ESRD patients. Nephrol Dial Transplant 2010 Nov 5. [Epubahead of print]
49. Beddhu S, Samore MH, Roberts MS, Stoddard GJ, Pappas LM, Cheung AK: Creatinine production, nutrition, and glomerularfiltration rate estimation. J Am Soc Nephrol 14:1000-1005, 2003
50. Chiu YL, Chien KL, Lini SL, Chen Ym, Tsai TJ, Wu KD: Outcomes of stage 3 to 5 chronic kidney disease before ESRD ata single center in Taiwan. Nephrol Clin Prac 109: c109-c118, 2008
51. Paniagua R, Amato D, Bonesh E, Guo A, Mujais S: Health related quality of life predicts outcomes but is not affected byperitoneal clearance: The ADEMEX trial. Kidney Int 67:1093-1104, 2005
52. Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Finkelstein FO: Health-related quality oflife in CKD patients: Correlates and evolution over time. ClinJ Am Soc Nephrol 4: 1293-1301, 2009
53. Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA: Health-related quality of life asa predictor of mortality and hospitalization: The dialysis outcomesand practice patterns study (DOPPS). Kidney Int 64:339-349, 2003
54. Gabbay E, Meyer KB, Griffith JL, Richardson MM, Miskulin DC: Temporal trends in the health-related quality of lifeamong hemodialysis patients in the United States. Clin J AmSoc Nephrol 5: 261-267, 2010
55. Tamura MK, Covinsky KE, Chertow GM, Yaffe K, Landefeld S, McCulloch CE: Functional status of elderly adults beforeand after initiation of dialysis. N Engl J Med 361: 1539-1547, 2009
56. Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenariansand nonagenarians starting dialysis in the United States. Ann Intern Med 146: 177-183, 2007
57. Metcalf W, Khan IH, Prescott GJ, Simpson K, Macleod AM: Hospitalization in the first year of renal replacementtherapy for end-stage renal disease. Q J Med 96: 899-909,2003
58. OHare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, Rodrigues RA, Allon M: When to refer patientswith chronic kidney disease for vascular access surgery:Should age be a consideration? Kidney Int 71: 555-561,2007
59. Wang AY-M, Lai K-N: The importance of residual renal functionin dialysis patients. Kidney Int 69: 1726-1732, 2006
60. Perl J, Bargman JM: The importance of residual kidney functionfor patients on dialysis: A critical review. Am J KidneyDis 53: 1068-1081, 2009
61. Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekhohlm I, Lindholm B, Stenvinkel P: Associationsbetween circulating inflammatory markers and residual renalfunction in CRF patients. Am J Kidney Dis 41: 1212-1216,2003
62. Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, De Caterina R, Zoccali C: Circulatingsoluble receptor of advanced glycation end product inverselycorrelates with atherosclerosis in patients with chronic kidneydisease. Kidney Int 77: 225-231, 2009
63. Jansen MAM, Hart AAM, Korevaar JC, Dekker FW, Boeschoeten EW, Krediet RT, for the NECOSAD Study Group: Predictorsof the rate of decline of residual renal function in incidentdialysis patients. Kidney Int 62:1046-1053, 2002
64. Berlanga JR, Marron B, Reyero A, Caramelo C, Ortiz A: Peritonealdialysis retardation of progression of advanced renalfailure. Perit Dial Int 22: 239-242, 2002
65. Eriksen BO, Ingebretsen OC: The progression of chronic kidneydisease: A 10-year population-based study of the effectsof gender and age. Kidney Int 69: 375-382, 2006
66. Taal MW, Brenner BM: Renal risk scores: Progress and prospects. Kidney Int 73: 1216-1219, 2008
67. Hall YN, Choi AI, Chertow GM, Bindman AB: Chronic kidneydisease in the urban poor. Clin J Am Soc Nephrol 5:828-835, 2010
68. Fried L: Higher incidence of ESRD than mortality in the AASKstudy. J Am Soc Nephrol 21: 1244-1246, 2010
69. Appel LJ, Wright JT Jr., Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X; AASK Collaborative Research Group: Intensiveblood pressure control in hypertensive chronic kidney disease. N Engl J Med 363: 918-929, 2010
70. Levin A, Djurdjiev O, Beaulieu M, Er L: Variability and riskfactors for kidney disease progression and death followingattainment of stage 4 CKD in a referred cohort. Am J KidneyDis 4: 661-671, 2008
71. Goldstein M, Yassa T, Dacouris N, McFarlane P: Multidisciplinarypredialysis care and morbidity and mortality of patientson dialysis. Am J Kidney Dis 44: 706-714, 2004
72. Wingard RL, Chan KE, Lazarus M, Hakim RM: The "right" ofpassage: surviving the first year of dialysis. Clin J Am SocNephrol 4: S114-S120, 2009
73. Tang SCW, Ho YW, Tang AWC, Cheng YY, Chiu FH, Lo WK, Lai KN: Delaying initiation of dialysis till symptomactic uraemia:Is it too late?. Nephrol Dial Transplant 22: 1926-1932,2007
74. Lamiere N, VanBiesen W: The initiation of renal-replacementtherapy: Just-in-time delivery. N Engl J Med 10: 1056, 2010
75. Curtis BM, Barrett BJ, Jindal K, Djurdjev O, Levin A, Barre P, Bernstein K, Blake P, Carlisle E, Cartier P, Clase C, Culleton B, Deziel C, Donnelly S, Ethier J, Fine A, Ganz G, Goldstein M, Kappel J, Karr G, Langlois S, Mendelssohn D, Muirhead N, Murphy B, Pylpchuk G, Toffelmire E; CREDA (CanadianRenal Disease Alliance): Canadian survey of clinical status atdialysis initiation 1998-1999: A multicenter prospective survey. Clin Nephrol 58: 282-288, 2002
76. Ifudu O, Dawood M, Homel P, Friedman EA: Timing of theinitiation of uremia therapy and survival in patients with progressiverenal disease. Am J Nephrol 18: 193-198, 1998